These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36734254)

  • 21. Predicted Immunogenicity of CDK12 Biallelic Loss-of-Function Tumors Varies across Cancer Types.
    Elliott A; Zhang J; Zhang Q; Swensen J; Martin D; Xiu J; Geynisman DM; Vaena D; Herzog TJ; Holloway RW; El-Deiry WS; Spetzler D; Heath E; Stafford P; Korn WM
    J Mol Diagn; 2021 Dec; 23(12):1761-1773. PubMed ID: 34562615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review.
    Chen Q; Zhong T
    Drug Des Devel Ther; 2015; 9():5115-22. PubMed ID: 26379424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis.
    Meng L; Yang Y; Hu X; Zhang R; Li X
    J Transl Med; 2023 Feb; 21(1):79. PubMed ID: 36739407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis.
    Cao J; Zhu X; Zhao X; Li XF; Xu R
    PLoS One; 2016; 11(7):e0158770. PubMed ID: 27368058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current progress and novel strategies that target CDK12 for drug discovery.
    Lei P; Zhang J; Liao P; Ren C; Wang J; Wang Y
    Eur J Med Chem; 2022 Oct; 240():114603. PubMed ID: 35868123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3.
    Zhong K; Luo W; Li N; Tan X; Li Y; Yin S; Huang Y; Fang L; Ma W; Cai Y; Yin Y
    Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38186306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis.
    Guo J; Fang J; Huang X; Liu Y; Yuan Y; Zhang X; Zou C; Xiao K; Wang J
    Int J Surg; 2018 Dec; 60():216-223. PubMed ID: 30468905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between sexual dysfunction and prostate cancer: a systematic review and meta-analysis.
    Dilixiati D; Kadier K; Laihaiti D; Lu JD; Azhati B; Rexiati M
    J Sex Med; 2023 Feb; 20(2):184-193. PubMed ID: 36763951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of pretreatment systemic immune-inflammation index in patients with prostate cancer: a meta-analysis.
    Zhang B; Xu T
    World J Surg Oncol; 2023 Jan; 21(1):2. PubMed ID: 36600256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer".
    Valle LF; Nickols NG; Yamoah K; Garraway IP; Maxwell KN; Lynch JA
    Oncologist; 2023 Nov; 28(11):e1129-e1130. PubMed ID: 37706534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinicopathological significance and prognostic value of programmed death-ligand 1 in prostate cancer: a meta-analysis of 3133 patients.
    Shen H; Liu J; Sun G; Yan L; Li Q; Wang Z; Xie L
    Aging (Albany NY); 2020 Dec; 13(2):2279-2293. PubMed ID: 33318295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDK12: an emerging therapeutic target for cancer.
    Lui GYL; Grandori C; Kemp CJ
    J Clin Pathol; 2018 Nov; 71(11):957-962. PubMed ID: 30104286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer.
    Kwon DH; Chou J; Yip SM; Reimers MA; Zhang L; Wright F; Dhawan MS; Borno HT; Desai A; Aggarwal RR; Wyatt AW; Small EJ; Alva AS; Chi KN; Feng FY; Koshkin VS
    Cancer; 2021 Jun; 127(12):1965-1973. PubMed ID: 33690902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical prognostic value of lncRNA LINC00675 in cancer patients: A meta-analysis.
    Hua H; Wang J; Zhong P; Mou T; Liu P; Xie F
    Medicine (Baltimore); 2021 Apr; 100(16):e25244. PubMed ID: 33879657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer.
    Zeng Z; He W; Jiang Y; Jiang H; Cheng X; Deng W; Zhou X; Zhang C; Wang G
    BMC Cancer; 2022 Nov; 22(1):1162. PubMed ID: 36357836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological and prognostic significance of osteopontin expression in patients with prostate cancer: a systematic review and meta-analysis.
    Yu A; Guo K; Qin Q; Xing C; Zu X
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 33635319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel germline EGFR variant p.R831H causes predisposition to familial CDK12-mutant prostate cancer with tandem duplicator phenotype.
    Qian K; Wang G; Ju L; Liu J; Luo Y; Wang Y; Peng T; Chen F; Zhang Y; Xiao Y; Wang X
    Oncogene; 2020 Oct; 39(44):6871-6878. PubMed ID: 32978518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
    Shao Y; Li W; Wang D; Wu B
    World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis.
    Tang L; Li X; Wang B; Luo G; Gu L; Chen L; Liu K; Gao Y; Zhang X
    PLoS One; 2016; 11(4):e0153981. PubMed ID: 27096158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer.
    Lautert-Dutra W; M Melo C; Chaves LP; Crozier C; P Saggioro F; B Dos Reis R; Bayani J; Bonatto SL; Squire JA
    Mol Cytogenet; 2024 May; 17(1):11. PubMed ID: 38704603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.